Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)
Price and Volume
Detailed Quote| Volume | 538,868 |
| Open | 39.09 |
| Bid (Size) | 40.25 (300) |
| Ask (Size) | 40.46 (300) |
| Prev. Close | 38.71 |
| Today's Range | 38.68 - 40.62 |
| 52wk Range | 22.96 - 43.15 |
| Shares Outstanding | 99,581,693 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Is Viking Therapeutics Stock Going to $100? ↗
July 01, 2026
Is Viking Therapeutics Stock Going to $100? ↗
June 12, 2026
Is Viking Therapeutics a Top Takeover Target? ↗
May 23, 2026
2 Stocks That Could Realistically Double by 2030 ↗
May 22, 2026
Could Viking Therapeutics Be the Next Eli Lilly? ↗
May 21, 2026
Best Weight Loss Drug Stocks to Buy in 2026 ↗
May 20, 2026
Frequently Asked Questions
Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 40.48
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 07/07/26 10:03 AM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 4.03B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.